Click here to post a new related report
No lucky surprise on Genentech drug
xperts who took an advance peek at the Avastin data found no reason to stop the trial early, an action often taken when an experimental treatment is so clearly successful that it becomes ethically questionable to withhold it from subjects in the trial's control group.
- Share:
-
-
-
-
-
-
Site Links
Contributions
- Sign up, and add your voice by contributing to allvoices
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
